Navigation Links
Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administration's Nationwide Prescription "Drug Take-Back Day"
Date:4/25/2012

DETROIT, April 25, 2012 /PRNewswire-USNewswire/ -- In a nationwide effort to prevent medication abuse and to rid homes of unwanted and unnecessary prescription drugs, Blue Cross Blue Shield of Michigan and Blue Care Network are supporting the Drug Enforcement Administration's National Prescription Drug Take-Back Day, taking place from 10 a.m. to 2 p.m. Saturday, April 28.

"Blue Cross Blue Shield of Michigan and Blue Care Network are proud to once again promote this worthwhile event," said James Lang, vice president of Pharmacy Services, Blue Cross Blue Shield of Michigan. "Not only does it provide our community with opportunities to safely and securely dispose of unused and expired medications, it also reinforces our goals of positively impacting the quality of people's health."

Michigan will have more than 180 locations available for the public to dispose unwanted prescription drugs. In the 2011 spring and fall take-back days, Michigan locations collected 10,634 pounds of unwanted pharmaceuticals. In the two-year history of the program, the DEA, in partnership with nearly 4,000 state and local law enforcement agencies throughout the nation, collected close to 500 tons of pills.

Studies show that a majority of abused prescription drugs are obtained from family and friends, often from the home medicine cabinet. More than 7 million Americans currently abuse prescription drugs, according to the 2010 Substance Abuse and Mental Health Services Administration's National Survey on Drug Use and Health. The Partnership for a Drug Free America reports that each day, approximately 2,500 teens use prescription drugs to get high for the first time.

A study by the Journal of Pediatrics reports a 30 percent increase in emergency room visits for children under age five due to medication poisoning for the period 2001 to 2008. Experts say usual methods of disposing unused medicines – flushing them down the toilet or throwing them in the t
'/>"/>

SOURCE Blue Cross Blue Shield of Michigan
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
3. YouthAIDS, Levis and BETs Rap It-Up Campaign Kick Off 2007 Kick Me Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country
4. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
5. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
6. Blue Cross Blue Shield Of Michigan Battles Sluggish Economy With Diverse Product Lineup
7. Discovering How Video Games Can Motivate Healthy Behaviors: More than $2 Million Awarded to 12 Research Teams Across U.S.
8. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
9. Abbotts Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
10. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
11. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... by Persistence Market Research "Global Market Study on ... to Witness Highest Growth by 2022", the global physiotherapy ... Bn by the end of 2015 and is expected ... 2015 to 2022, to account for US$23.7 Bn by ...
(Date:8/3/2015)... 3, 2015  CytRx Corporation (NASDAQ: CYTR ), ... today reported financial results for the three months ended ... recent accomplishments and upcoming milestones for its clinical development ... been very productive for CytRx. Enrollment in our ongoing ... soft tissue sarcoma (STS) continues on track to be ...
(Date:8/3/2015)... 2015  Array BioPharma Inc. (NASDAQ: ARRY ... and full year of its fiscal year ended ... Executive Officer of Array, noted, "Binimetinib and encorafenib, two ... track for regulatory submissions in 2016. Additional data ... BRAF-mutant colorectal cancer further validate the value of ...
Breaking Medicine Technology:Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 2Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 3Global Physiotherapy Equipment Market Will Reach US$ 23.7 Billion by 2022: Persistence Market Research 4CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 2Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 3Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 4Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 5Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 6Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 7Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 8Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 9Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 10Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 11Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2015 12
... Feb. 10 Choosing foods bearing the organic label ... products they buy have been produced without the use of antibiotics, ... CBS Evening News with Katie Couric segment on livestock ... recognize and respect the powerful nature of antibiotics. As a result, ...
... , Evaluate Analgesic Efficacy and Safety ... Following Total Knee Replacement Surgery , SYDNEY ... QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced ... (Study 009) to evaluate analgesic efficacy and safety of MoxDuo™IR, ...
Cached Medicine Technology:Organic Is Answer to Those Seeking Foods Produced Without Antibiotics 2Organic Is Answer to Those Seeking Foods Produced Without Antibiotics 3QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission 2QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission 3QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission 4QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission 5
(Date:8/4/2015)... ... August 04, 2015 , ... The Law Offices of Ben C. ... claims dealing with Inferior Vena Cava Filters (“IVC Filters”). , As lead IVC filter ... Cook IVC Filter clients under In re Cook Medical, Inc., IVC Filters Marketing, Sales ...
(Date:8/4/2015)... ... August 04, 2015 , ... In the most recent ... & Johnson report that a new location for pretrial proceedings is under consideration, ... and cancer warning information at their website, the Talcum Powder Cancer Lawsuit Center. ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... independent educational grants in support of an interaction simulation session entitled "NOACS: What ... is jointly provided by Medical Learning Institute Inc. and EDUmotion US LLC. , ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... press at its Denver facility that will usher in a new standard of ... Lightning Labels more effectively meet its twin objectives of quality and quantity ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... "The Winscribe Text results have been impressive so far". , Mr Cauchois ... management from Winscribe's French sales partner Dicma and the healthcare technology offered by ...
Breaking Medicine News(10 mins):Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 2Health News:Law Offices of Ben C. Martin in Dallas Files New IVC Filter Complications Lawsuits and Pursues Settlements 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 2Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 3Health News:Talcum Powder Lawsuits: Plaintiffs Suggest Middlesex County Transfer 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Lightning Labels Installs State-of-the-Art Digital Press 2Health News:Lightning Labels Installs State-of-the-Art Digital Press 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 2Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 3Health News:The Oscar Lambret Center (France) Completes First Stage Of Winscribe Text Rollout 4
... published whole-genome sequences of not just one, but two supercentenarians, ... common genetic phenomena contribute to the genetic background of extreme ... by researchers from the Boston University Schools of Public Health ... to researchers around the world at the NIH data repository. ...
... are studying biomarkers substances present in spinal fluid and ... 140 people with mild memory impairment, showing that a certain ... high levels of the substance tau) indicate a high risk ... as 91 per cent of the patients with mild memory ...
... , MONDAY, Jan. 2 (HealthDay News) -- A small study ... as a treatment for general depression, may also help patients ... surgery necessary to allow deep brain stimulation is extremely expensive. ... early to know for sure if the treatment is appropriate ...
... A hormone derived from visceral fat called adiponectin may play ... dementia and Alzheimer disease (AD) in women, according to a ... , one of the JAMA/Archives journals. The number of ... the next 20 years from the current number of about ...
... , MONDAY, Jan. 2 (HealthDay News) -- Searching for ... found a marker of change in the brain that precedes the ... indicator of trouble to come, they say, is a shift in ... the brain and spinal cord. Among patients already diagnosed with mild ...
... whether or not you will develop exfoliation syndrome (ES) -- ... open-angle glaucoma and increased risk of cataract as well as ... does matter. "Although many studies from around the world ... of the basic descriptive epidemiologic features, which may help shed ...
Cached Medicine News:Health News:Genetic predisposition to disease common in 2 supercentenarians: New study 2Health News:Alzheimer's damage occurs early 2Health News:Study Looks at Deep Brain Stimulation in Bipolar Patients 2Health News:Study Looks at Deep Brain Stimulation in Bipolar Patients 3Health News:Study finds another potential risk factor for developing dementia and Alzheimer's disease in women 2Health News:Changes in Cerebrospinal Fluid May Signal Early Alzheimer's 2Health News:Outside temperatures, sun exposure and gender may trigger glaucoma 2Health News:Outside temperatures, sun exposure and gender may trigger glaucoma 3
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
... Maximum, Maximum Xtra, and Maximum ACT ... standard and specialty hemostasis introducers in ... the premier hemostasis introducers for use ... including angiography, angioplasty, stenting, atherectomy, temporary ...
St. Jude Medical's line of guiding introducers includes Swartz Series, SAFL, SEPT, CSTA, RAMP, and 2 piece steerable...
Rapid Exchange Stent Delivery System with Hepacoat...
Medicine Products: